2019
DOI: 10.1177/2050313x19848597
|View full text |Cite
|
Sign up to set email alerts
|

Acute ST-elevation myocardial infarction in a young patient with antiphospholipid syndrome

Abstract: Acute coronary syndrome rarely occurs in young individuals and is seldomly associated with antiphospholipid syndrome. We report the case of a 26-year-old Hispanic man who presented with acute ST-elevation myocardial infarction and was treated with urgent percutaneous transluminal coronary angioplasty. He experienced stent thrombosis within 48 h of intervention and subsequently developed a left apical thrombus. Hypercoagulable state studies were obtained at admission and 12 weeks after the event establishing th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…One of the critical challenges in this case was the coexistence of APLS and SLE, as these autoimmune disorders often overlap and potentiate each other's clinical manifestations. The development of ACS in a young patient with CAPS is rare, emphasizing the need for increased awareness of potential cardiovascular complications in this population [6].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…One of the critical challenges in this case was the coexistence of APLS and SLE, as these autoimmune disorders often overlap and potentiate each other's clinical manifestations. The development of ACS in a young patient with CAPS is rare, emphasizing the need for increased awareness of potential cardiovascular complications in this population [6].…”
Section: Discussionmentioning
confidence: 99%
“…The initiation and titration of anticoagulation regimens are paramount but must be approached with caution, considering the patient's hypercoagulable state and potential bleeding risks [7]. Recent guidelines have emphasized the importance of tailoring anticoagulation therapy to the specific presentation of CAPS, considering the extent and type of thrombotic events and the presence of comorbidities [6]. As seen in this case, therapeutic decisions require clinical judgment and adaptability, such as deferring therapeutic hypothermia due to hypercoagulability and adjusting anticoagulant dosing following an acute blood loss anemia episode.…”
Section: Discussionmentioning
confidence: 99%